drug · vaccine component
Coronavirus Disease 2019 (COVID-19) vaccine
Phase 3updated 6mo agoby $SNY Sanofi🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 6Vaccine component drug with a maximum clinical stage of Approval, with an approval for covid-19.
targets
Spike glycoprotein
all catalysts(0)
nothing on the calendar yet
Trials studying Coronavirus Disease 2019 (COVID-19) vaccine
- phase2Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
- phase2A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
- phase1Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19
- —COVID-19 Vaccines International Pregnancy Exposure Registry
- EP1Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
- —A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
- phase1A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
- phase4Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
News(10)
- STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and moreMerck is entering a research collaboration with Isomorphic Labs, the AI drug designer built on a Nobel-winning technologystat · 1h ago
- STAT+: NIH to move last group of its research chimps to a sanctuaryThe last chimpanzees owned by the U.S. government and still living in a laboratory will be moved to a sanctuary next year.stat · 18h ago
- Pfizer leaps into ‘in vivo’ CAR-T with latest China dealThe potentially $2.6 billion collaboration puts Pfizer into a competitive race to treat autoimmune conditions by reprogramming cells inside the body.biopharma_dive · 23h ago
- STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and moreThe Trump administration is pulling the nomination of Heidi Overton to lead the FDA over concerns she lacked support to get confirmed by the Senatestat · 1d ago
- STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and moreThe FDA approved a breast cancer drug from Roche, teeing up the launch of what the company has said could become its top-selling productstat · 2d ago
- STAT+: Newer GLP-1 drugs to combat obesity may be the next global battleground over access to medicines, expert warnsHow obesity medications may become the next big battleground over access to medicines in lower-income countries.stat · 2d ago
- STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and moreDuring July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous yearstat · 3d ago
- Moderna notches small profit as it prioritizes work on cancer vaccinesInternational Covid-19 vaccine sales helped propel Moderna to its first profitable quarter in two years, as its return to cancer leaps forward. “I don't normally use a lot of hyperbole, but it was…endpoints · 13d ago
- STAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHARFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.stat · 21d ago
- How voters feel about trans rights and abortion access will soon be put to the testHow do voters feel about trans students participating in school sports teams? Or abortion access? The U.S. is about to find out.stat · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that